ClinicalTrials.gg

Lower Urinary Tract Symptoms clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 417 studies for Lower Urinary Tract Symptoms across more than 10 countries. 110 are recruiting or about to start. 176 of them are mainly about Lower Urinary Tract Symptoms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16. Counting its 7 narrower conditions too, such as Urinary Incontinence: 2,742 studies, 500 open.

Status

Completed
220
Recruiting
59
Not yet recruiting
45
Status unknown
41
Active, not recruiting
17
Terminated
16

Phase

Phase 2
37
Phase 4
34
Phase 3
29
Phase 1
11
Early Phase 1
2

Where

United States
111
Turkey
45
Taiwan
29
France
26
United Kingdom
23
Egypt
22

Who develops what

Add Lower Urinary Tract Symptoms to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 2 programs from 1 company, 0 with this as their studies’ main aim; 1 with a live phase 3 study; 1 primary completion in the next 12 months.

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
TamsulosinRecent, repeatedPhase 4 trial recorded
Evidence
  • NCT07134907 · Shanghai Huilun Pharmaceutical Co., Ltd. · Phase 4 · comparator · “Tamsolusin” · registered Aug 2025
  • NCT05551221 · xintian pharmaceutical · Phase 4 · comparator · “Tamsulosin” · registered Sep 2022
  • NCT02757768 · Astellas Pharma Inc · Phase 4 · background · “Tamsulosin Hydrochloride” · registered Apr 2016
  • NCT02003742 · RECORDATI GROUP · Phase 3 · comparator · “Tamsulosin” · registered Dec 2013
  • NCT01018511 · Astellas Pharma Inc · Phase 3 · comparator · “tamsulosin hydrochloride OCAS 0.4 mg” · registered Nov 2009
Boehringer Ingelheim23% of its industry studies22 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 2 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (1)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • Jan 2027 est.H077 · Shanghai Huilun Pharmaceutical Co., Ltd. · Phase 3 named, not the main aimNCT07146386 A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia — primary endpoint: changes in International Prostatism Symptom Score (IPSS) at 12 weeks from baseline · 728 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Lower Urinary Tract Symptoms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Antimuscarinics 1 open · 5-alpha reductase inhibitors 3

Coming up

39studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 59 Lower Urinary Tract Symptoms studies recruiting now, 39 (66%) set no upper age limit and 11 (19%) stop at 75 or younger. 7 (12%) take children under 18. 7 (12%) are for women only and 34 (58%) for men only; 11 (19%) take healthy volunteers.

Recruiting studies that take each age, of 59
AgeWomenMen
104 (7%)6 (10%)
1815 (25%)28 (47%)
3017 (29%)28 (47%)
4019 (32%)37 (63%)
5019 (32%)46 (78%)
6517 (29%)44 (75%)
7516 (27%)41 (69%)
8515 (25%)37 (63%)

Across all 417 studies, recruiting or not: 16% stop at 75 or younger and 12% at 65; 11% take children; 17% are for women only and 56% for men only; 15% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Lower Urinary Tract Symptoms studies take

Of 18 phase 4 interventional studies under Lower Urinary Tract Symptoms, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 423 mo9–29 · 18 studies——
Interventional, no phase27 mo11–54 · 119 studies—27 mo12–59 · 98 studies
Observational33 mo11–70 · 61 studies—35 mo10–70 · 56 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 18, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 417. Browse all 417 → or search them.